RESEARCHER PROFILE

Goce B. Spasovski

← Back to Ss. Cyril and Methodius University in Skopje

G

Ss. Cyril and Methodius University in Skopje

Dialysis and Renal Disease ManagementChronic Kidney Disease and DiabetesRenal Transplantation Outcomes and TreatmentsParathyroid Disorders and TreatmentsOrgan Donation and Transplantation

Goce B. Spasovski works in Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Renal Transplantation Outcomes and Treatments, Parathyroid Disorders and Treatments, Organ Donation and Transplantation. Recorded institutional associations include Ss. Cyril and Methodius University in Skopje.

359Publications
9,953Citations
41H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Clinical practice guideline on diagnosis and treatment of hyponatraemia

    2014 · 1,020 citations
  2. Clinical practice guideline on diagnosis and treatment of hyponatraemia

    2014 · 855 citations
  3. Chronic kidney disease as cause of cardiovascular morbidity and mortality

    2005 · 613 citations
  4. Clinical practice guideline on diagnosis and treatment of hyponatraemia

    2014 · 579 citations
  5. Recommendations for Biomarker Identification and Qualification in Clinical Proteomics

    2010 · 334 citations
  6. A multicenter study on the effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients

    2003 · 326 citations
  7. European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care: FIGURE 1.

    2014 · 309 citations
  8. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

    2020 · 262 citations
  9. Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

    2015 · 242 citations
  10. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D

    2020 · 207 citations
  11. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism

    2014 · 181 citations
  12. Implementation of proteomic biomarkers: making it work

    2012 · 169 citations
  13. Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up

    2006 · 162 citations
  14. Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis

    2003 · 135 citations
  15. Data Sharing Under the General Data Protection Regulation

    2021 · 133 citations
  16. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

    2016 · 122 citations
  17. Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients

    2003 · 117 citations
  18. Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

    2014 · 113 citations
  19. Guideline

    2013 · 107 citations
  20. Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    2016 · 105 citations
  21. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

    2021 · 105 citations
  22. Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?

    2017 · 97 citations
  23. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

    2019 · 94 citations
  24. Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease

    2009 · 84 citations
  25. Mild cognitive impairment and kidney disease: clinical aspects

    2019 · 81 citations

← Return to the university profile